🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In second line with advanced or recurrent biliary tract cancer refractory t...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2015-07-29
Trial ID
NCT03464968
Treatments Being Tested
Randomized, open label, multicentre phase II trial followed by phase III co...
Status
Completed
Location
CRLC Val d'Aurelle
Start Date
2004-04
Trial ID
NCT00208260
Treatments Being Tested
Approximately 40% of colorectal cancer patients will develop colorectal liv...
Status
Unknown
Location
Severance Hospital, Yonsei University Health System
Start Date
2021-11-01
Trial ID
NCT05103020
First line chemotherapy treatment regimens for metastatic colorectal cancer...
Status
Unknown
Location
Associació Catalana per la Recerca Oncològica i les Seves Implicacions Sanitaries i Socials
Start Date
2009-09
Trial ID
NCT01144195
Treatments Being Tested
This is a single-arm, open-label, phase I study of combination therapy with...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2011-09
Trial ID
NCT01434069
Treatments Being Tested
The purpose of this interventional study is to assess the progression free ...
Status
Unknown
Location
Universitätsmedizin Mainz
Start Date
2011-01
Trial ID
NCT01315990
Treatments Being Tested
The AMALTHEA (Aflibercept MAintenance after first-Line THErapy with FOLFIRI...
Status
Completed
Location
Agios Georgios Chania General Hospital
Start Date
2014-05-26
Trial ID
NCT02129257
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to kill tumor ...
Status
Terminated
Location
Kaiser Permanente - Deer Valley
Start Date
2010-08
Trial ID
NCT01189227
Treatments Being Tested
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282
This is a Phase 1 dose-escalation study with three dose levels to determine...
Status
Completed
Location
New York Presbyterian Hospital/ Weill Cornell Medical College
Start Date
2010-12
Trial ID
NCT01274624
Treatments Being Tested